163
Views
3
CrossRef citations to date
0
Altmetric
Derleme/Review

Today's Psychopharmacological Treatments: Results, Problems, New Perspectives

Günümüzde Psikofarmakolojik Tedavi: Sonuçlar, sorunlar, yeni açılımlar

, M.D. (Professor of Psychiatry, Editor -in- Chief, Bulletin of Clinical Psychopharmacology) , , Ph.D. (Professor of Pharmacology, Psychopharmacology Editor of Bulletin of Clinical Psychopharmacology) , (Statistical Editors of Bulletin of Clinical Psychopharmacology) & (Statistical Editors of Bulletin of Clinical Psychopharmacology)
Pages 198-204 | Received 05 Apr 2012, Accepted 10 Apr 2012, Published online: 08 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hasan Karadağ, Ahmet Kokurcan, Seher Olga Güriz, Mehlika Atmar & Sibel Örsel. (2019) Assessing the treatment adherence and clinical correlates of low adherence among bipolar disorder outpatients: a cross-sectional study. Psychiatry and Clinical Psychopharmacology 29:4, pages 558-564.
Read now
Mesut Cetin. (2015) Treatment of Schizophrenia: Past, Present and Future. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 25:2, pages 95-99.
Read now
Mesut Cetin. (2013) Asenapine: A Novel Hope in the Treatment of Schizophrenia and Manic and Mixed Episodes of Bipolar I Disorder. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 23:1, pages 99-106.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.